178 related articles for article (PubMed ID: 16466948)
1. The platelet P2 receptors in arterial thrombosis.
Gachet C; Léon C; Hechler B
Blood Cells Mol Dis; 2006; 36(2):223-7. PubMed ID: 16466948
[TBL] [Abstract][Full Text] [Related]
2. The platelet P2 receptors as molecular targets for old and new antiplatelet drugs.
Gachet C
Pharmacol Ther; 2005 Nov; 108(2):180-92. PubMed ID: 15955565
[TBL] [Abstract][Full Text] [Related]
3. The platelet P2 receptors in thrombosis.
Gachet C; Hechler B
Semin Thromb Hemost; 2005 Apr; 31(2):162-7. PubMed ID: 15852219
[TBL] [Abstract][Full Text] [Related]
4. ADP receptors of platelets and their inhibition.
Gachet C
Thromb Haemost; 2001 Jul; 86(1):222-32. PubMed ID: 11487010
[TBL] [Abstract][Full Text] [Related]
5. Identification, characterization, and inhibition of the platelet ADP receptors.
Gachet C
Int J Hematol; 2001 Dec; 74(4):375-81. PubMed ID: 11794691
[TBL] [Abstract][Full Text] [Related]
6. Platelet P2 receptors: old and new targets for antithrombotic drugs.
Cattaneo M
Expert Rev Cardiovasc Ther; 2007 Jan; 5(1):45-55. PubMed ID: 17187456
[TBL] [Abstract][Full Text] [Related]
7. Platelet activation by ADP: the role of ADP antagonists.
Gachet C
Ann Med; 2000 Dec; 32 Suppl 1():15-20. PubMed ID: 11209975
[TBL] [Abstract][Full Text] [Related]
8. Regulation of platelet functions by P2 receptors.
Gachet C
Annu Rev Pharmacol Toxicol; 2006; 46():277-300. PubMed ID: 16402906
[TBL] [Abstract][Full Text] [Related]
9. P2 receptors, platelet function and pharmacological implications.
Gachet C
Thromb Haemost; 2008 Mar; 99(3):466-72. PubMed ID: 18327393
[TBL] [Abstract][Full Text] [Related]
10. Molecular identification and characterization of the platelet ADP receptor targeted by thienopyridine antithrombotic drugs.
Foster CJ; Prosser DM; Agans JM; Zhai Y; Smith MD; Lachowicz JE; Zhang FL; Gustafson E; Monsma FJ; Wiekowski MT; Abbondanzo SJ; Cook DN; Bayne ML; Lira SA; Chintala MS
J Clin Invest; 2001 Jun; 107(12):1591-8. PubMed ID: 11413167
[TBL] [Abstract][Full Text] [Related]
11. ADP receptors--targets for developing antithrombotic agents.
Kunapuli SP; Ding Z; Dorsam RT; Kim S; Murugappan S; Quinton TM
Curr Pharm Des; 2003; 9(28):2303-16. PubMed ID: 14529392
[TBL] [Abstract][Full Text] [Related]
12. P2Y12 receptor in platelet activation.
Kim S; Kunapuli SP
Platelets; 2011; 22(1):56-60. PubMed ID: 21231822
[TBL] [Abstract][Full Text] [Related]
13. The role of ADP receptors in platelet function.
Murugappa S; Kunapuli SP
Front Biosci; 2006 May; 11():1977-86. PubMed ID: 16368572
[TBL] [Abstract][Full Text] [Related]
14. Monitoring platelet inhibition after clopidogrel with the VerifyNow-P2Y12(R) rapid analyzer: the VERIfy Thrombosis risk ASsessment (VERITAS) study.
Malinin A; Pokov A; Spergling M; Defranco A; Schwartz K; Schwartz D; Mahmud E; Atar D; Serebruany V
Thromb Res; 2007; 119(3):277-84. PubMed ID: 16563469
[TBL] [Abstract][Full Text] [Related]
15. P2Y receptor antagonists in thrombosis.
Boeynaems JM; van Giezen H; Savi P; Herbert JM
Curr Opin Investig Drugs; 2005 Mar; 6(3):275-82. PubMed ID: 15816504
[TBL] [Abstract][Full Text] [Related]
16. P2Y12 regulates platelet adhesion/activation, thrombus growth, and thrombus stability in injured arteries.
Andre P; Delaney SM; LaRocca T; Vincent D; DeGuzman F; Jurek M; Koller B; Phillips DR; Conley PB
J Clin Invest; 2003 Aug; 112(3):398-406. PubMed ID: 12897207
[TBL] [Abstract][Full Text] [Related]
17. The P2 receptors in platelet function.
Hechler B; Cattaneo M; Gachet C
Semin Thromb Hemost; 2005 Apr; 31(2):150-61. PubMed ID: 15852218
[TBL] [Abstract][Full Text] [Related]
18. Platelet aggregometry and receptor binding to predict the magnitude of antithrombotic and bleeding time effects of clopidogrel in rabbits.
Wong PC; Crain EJ; Watson CA; Jiang X; Hua J; Bostwick JS; Ogletree ML; Schumacher WA; Rehfuss R
J Cardiovasc Pharmacol; 2007 May; 49(5):316-24. PubMed ID: 17513951
[TBL] [Abstract][Full Text] [Related]
19. Discovery of 2-(phenoxypyridine)-3-phenylureas as small molecule P2Y1 antagonists.
Chao H; Turdi H; Herpin TF; Roberge JY; Liu Y; Schnur DM; Poss MA; Rehfuss R; Hua J; Wu Q; Price LA; Abell LM; Schumacher WA; Bostwick JS; Steinbacher TE; Stewart AB; Ogletree ML; Huang CS; Chang M; Cacace AM; Arcuri MJ; Celani D; Wexler RR; Lawrence RM
J Med Chem; 2013 Feb; 56(4):1704-14. PubMed ID: 23368907
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of platelet functions and thrombosis through selective or nonselective inhibition of the platelet P2 receptors with increasing doses of NF449 [4,4',4'',4'''-(carbonylbis(imino-5,1,3-benzenetriylbis-(carbonylimino)))tetrakis-benzene-1,3-disulfonic acid octasodium salt].
Hechler B; Magnenat S; Zighetti ML; Kassack MU; Ullmann H; Cazenave JP; Evans R; Cattaneo M; Gachet C
J Pharmacol Exp Ther; 2005 Jul; 314(1):232-43. PubMed ID: 15792995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
